FDA Inspection 1246877 — Gulf Coast Regional Blood Center at Westchase
The FDA completed an inspection of Gulf Coast Regional Blood Center at Westchase on September 12, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 12, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)